Valuation Clinuvel Pharmaceuticals Limited Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 16:30:00 2026-07-29 EDT			5-day change	1st Jan Change
6.825 ^USD	-2.64%		-2.50%	-19.52%

09:15pm	Clinuvel Pharmaceuticals Strengthens Supply Chain as Part of Commercial Preparations for North American Vitiligo Market	MT
07-28	Clinuvel Pharmaceuticals Ltd Provides Update On SCENESSE In Vitiligo	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,517	733.7	883.5	769.8	520.3	483.6	-	-
Change	-	-51.63%	20.4%	-12.87%	-32.41%	-7.05%	-	-
Enterprise Value (EV) ¹	1,434	612.2	726.6	585.9	296.2	230.9	199	164.4
Change	-	-57.31%	18.69%	-19.37%	-49.45%	-22.03%	-13.82%	-17.37%
P/E	63.4x	36.8x	30.3x	22x	14.5x	13.5x	12.8x	10x
PBR	15.4x	5.84x	5.37x	3.79x	2.17x	1.76x	1.58x	1.42x
PEG	-	-2.2x	0.6x	1.2x	5.06x	-9.69x	2.26x	0.4x
Capitalization / Revenue	31.6x	11.2x	11.3x	8.73x	5.48x	4.87x	4.62x	3.74x
EV / Revenue	29.9x	9.32x	9.28x	6.64x	3.12x	2.33x	1.9x	1.27x
EV / EBITDA	55x	16.4x	19.5x	12x	6.84x	5.58x	4.49x	3.44x
EV / EBIT	56.8x	16.7x	20x	12.3x	7.03x	5.77x	4.6x	3.52x
EV / FCF	77.9x	15.5x	20.2x	18.6x	7.26x	7.29x	5.48x	2.97x
FCF Yield	1.28%	6.44%	4.94%	5.37%	13.8%	13.7%	18.3%	33.6%
Dividend per Share ²	0.025	0.04	0.05	0.05	0.05	0.0611	0.08	0.1114
Rate of return	0.08%	0.27%	0.28%	0.33%	0.48%	0.64%	0.83%	1.16%
EPS ²	0.484	0.403	0.591	0.698	0.718	0.708	0.7482	0.9547
Distribution rate	5.17%	9.93%	8.46%	7.16%	6.96%	8.64%	10.7%	11.7%
Net sales ¹	47.98	65.72	78.32	88.18	95.02	99.21	104.6	129.3
EBITDA ¹	26.1	37.44	37.2	48.95	43.3	41.39	44.34	47.75
EBIT ¹	25.24	36.68	36.41	47.81	42.12	40.05	43.25	46.76
Net income ¹	24.73	20.88	30.6	35.64	36.17	35.72	37.66	48.15
Net Debt ¹	-82.69	-121.5	-156.8	-183.9	-224.1	-252.7	-284.6	-319.2
Reference price ²	30.700	14.850	17.880	15.370	10.380	9.590	9.590	9.590
Nbr of stocks (in thousands)	49,410	49,410	49,410	50,083	50,124	50,428	-	-
Announcement Date	8/26/21	8/30/22	8/29/23	8/28/24	8/27/25	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.39x	3.96x	10.22x	0.56%	70.73B
UCB	26.81x	5.55x	16.3x	0.59%	54.27B
SAMSUNG BIOLOGICS CO.,LTD.	37.72x	12.9x	24.55x	-.--%	49.28B
CSL LIMITED	-44.25x	3.17x	9.36x	3.41%	39.94B
BIOGEN INC.	25.48x	3.48x	11.99x	-.--%	30.36B
INCYTE CORPORATION	61.3x	3.69x	34.6x	-.--%	25.96B
MODERNA, INC.	-6.44x	8.96x	-5.51x	-.--%	22.14B
INNOVENT BIOLOGICS, INC.	64.91x	6.37x	43.87x	-.--%	19.96B
BRIDGEBIO PHARMA, INC.	-38.46x	18.32x	-50.14x	-.--%	16.77B
Average	16.16x	7.38x	10.58x	0.51%	36.6B
Weighted average by Cap.	17.36x	6.61x	13.25x	0.63%